|
Volumn 359, Issue 2, 2008, Pages 200-202
|
Quality of life and satisfaction with outcome among prostate-cancer survivors [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HORMONE;
ANTIANDROGEN;
PROSTAGLANDIN E1;
SILDENAFIL;
TADALAFIL;
VARDENAFIL;
BRACHYTHERAPY;
CANCER RADIOTHERAPY;
CANCER SURVIVOR;
HIGH RISK PATIENT;
HORMONAL THERAPY;
HUMAN;
LETTER;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
QUALITY OF LIFE;
SEXUAL FUNCTION;
TREATMENT OUTCOME;
ADJUVANT CHEMOTHERAPY;
MALE;
NOTE;
PROSTATE TUMOR;
PSYCHOLOGICAL ASPECT;
SEXUAL BEHAVIOR;
ERECTILE DYSFUNCTION;
PROSTHESIS;
ANDROGEN ANTAGONISTS;
CHEMOTHERAPY, ADJUVANT;
HUMANS;
MALE;
PATIENT SATISFACTION;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
SEXUAL BEHAVIOR;
ERECTILE DYSFUNCTION;
|
EID: 46949086558
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc080867 Document Type: Letter |
Times cited : (14)
|
References (5)
|